Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection
|更新时间:2023-05-17
|
Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection
Chinese Journal of Experimental Traditional Medical FormulaeVol. 29, Issue 7, Pages: 185-192(2023)
XIE Junjie,TAN Peng,ZHENG Chuan,et al.Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(07):185-192.
XIE Junjie,TAN Peng,ZHENG Chuan,et al.Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(07):185-192. DOI: 10.13422/j.cnki.syfjx.20220758.
Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection
To establish a rapid screening method for influenza virus neuraminidase(NA) inhibitors sourced from Chinese medicines based on fluorescence detection.
Method
2
The method was constructed based on the principle that after the reaction of the test sample and a certain amount of NA, the activity of some NA will be inhibited by the test sample, and the NA that is still active after the addition of the substrate can generate fluorescence at a specific wavelength when combined with the fluorescent substrate, and the inhibition rate of the test sample on NA was calculated according to the measured fluorescence intensity, so as to evaluate the
in vitro
inhibitory activity of the test sample on NA. A total of 49 high-purity chemical components from 12 Chinese medicines were used to evaluate the
in vitro
anti-NA activity by the established method. The theoretical calculated values of binding energy and inhibition constant after docking between the NA protein receptor and the test sample were used to prove the accuracy of the experimental results. The established method was applied to detect the
in vitro
NA inhibitory activity of different batches of Banlangen granules and Kangbingdu granules, so as to evaluate the quality consistency among different batches of samples.
Result
2
The methodological examination results showed that the method had good accuracy and repeatability. The screening results of 49 components showed that 22 of them had strong
in vitro
inhibitory activity against NA than peramivir [half inhibitory concentration(IC
50
) was 131.2 μmol·L
-1
], such as schaftoside, isoorientin, chebulinic acid, menthone and isoschaftoside. The inhibitory activity of the remaining 27 components was weaker than that of peramivir. The molecular docking results showed that the theoretical calculation results of binding energies and inhibition constants of most compounds were basically consistent with the experimental results. The test results of the inhibitory activity of 12 batches of Banlangen granules on NA showed that the quality consistency among samples A1, A2, B2, C1, C2, E2 and F2 was good. The analysis results of the inhibitory activity of 9 batches of Kangbingdu granules produced by the same manufacturer on NA showed that the inhibitory rates of samples K1 to K9 were 37.68%, 36.18%, 31.37%, 33.98%, 40.36%, 33.76%, 40.69%, 41.08%, 40.06% when the concentration of 0.02 g·mL
-1
, and the average inhibitory rate was 37.24%.
Conclusion
2
In this paper, we successfully established an analytical method that can be used to rapidly evaluate whether Chinese medicines (derived from chemical components of traditional Chinese medicine or proprietary Chinese medicines) have
in vitro
anti-NA activity, which can be a powerful supplement to the existing screening methods for influenza virus NA inhibitors. And this method was used to screen 22 compounds from 12 Chinese medicines with good
in vitro
inhibitory activity against NA, which can provide candidate compounds for the development of anti-influenza small molecule drugs.
关键词
Keywords
references
PAULES C , SUBBARAO K . Influenza [J]. Lancet , 2017 , 390 ( 10095 ): 697 - 708 .
KWONG J C , SCHWARTZ K L , CAMPITELLI M A , et al . Acute myocardial infarction after laboratory-confirmed influenza infection [J]. N Engl J Med , 2018 , 378 ( 4 ): 345 - 353 .
GANDHI R T , LYNCH J B , DEL-RIO C . Mild or moderate COVID-19 [J]. N Engl J Med , 2020 , 383 ( 18 ): 1757 - 1766 .
MARR L C , TANG J W , VAN-MULLEKOM J , et al . Mechanistic insights into the effect of humidity on airborne influenza virus survival,transmission and incidence [J]. J R Soc Interface , 2019 , 16 ( 150 ): 20180298 .
JACKSON M L , CHUNG J R , JACKSON L A , et al . Influenza vaccine effectiveness in the united states during the 2015—2016 season [J]. N Engl J Med , 2017 , 377 ( 6 ): 534 - 543 .
PENG X Y , XIAO Y C , LI L , et al . Curative efficacy and safety of peramivir in the treatment of children suspected with influenza [J]. Eur J Inflamm , 2020 , doi: 10.1177/2058739220946139 http://dx.doi.org/10.1177/2058739220946139 .
YU G Y , FANG D . Evaluation of neuraminidase inhibitory activity of compounds and extracts from traditional medicines by HPLC-FLD [J]. Int J Anal Chem , 2021 , 2021 : 6694771 .
LIU J W , ZU M , CHEN K T , et al . Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines [J]. BMC Complement Altern Med , 2018 , 18 ( 1 ): 102 .
ZHANG J J , LIU T , TONG X M , et al . Identification of novel virus inhibitors by influenza a virus specific reporter cell based screening [J]. Antiviral Res , 2012 , 93 ( 1 ): 48 - 54 .
Mahoniae Caulis Alkaloids Ameliorate Depression by Regulating Synaptic Plasticity via cAMP Pathway
Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure
Effect and Mechanism of Angelicae Sinensis Radix-Polygonati Rhizoma Herb Pair in Treatment of Simple Obesity
Analysis of Mechanism of Xingpi Capsules in Treatment of Functional Dyspepsia Based on Transcriptomics
Screening of Anti-breast Cancer Active Ingredients in Famous Classical Formula Yanghetang
Related Author
HE Junhui
JIA Chunlian
LAI Kedao
ZHOU Guili
ZHOU Rongfei
LI Yi
LI Dongmei
XIE Jiaxiu
Related Institution
Key Laboratory of Chemistry and Engineering of Forest Products, National Ethnic Affairs Commission, Guangxi Key Laboratory of Chemistry and Engineering of Forest Products/Guangxi Collaborative Innovation Center for Chemistry and Engineering of Forest Products, School of Chemistry and Chemical Engineering, Guangxi Minzu University
Guangxi Key Laboratory of Chinese Medicine Quality Standard, Guangxi Institute of Chinese Medicine and Pharmaceutical Science
Guangxi Medical University
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Jiangxi Province Key Laboratory of Traditional Chinese Medicine(TCM) Pharmacology,Institute of TCM Health Industry,China Academy of Chinese Medical Sciences